FGF19 and metabolic dysfunction-associated steatotic liver disease: As expected, FGF19 correlated negatively with C4 (rs -0.43, p<0.001) but neither FGF19 or C4 correlated significantly with the NAFLD fibrosis score or Fibroscan score (Table 3).